Log in to save to my catalogue

Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease

Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7603860

Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

Alzheimer’s disease (AD) causes unrelenting, progressive cognitive impairments, but its course is heterogeneous, with a broad range of rates of cognitive decline
1
. The spread of tau aggregates (neurofibrillary tangles) across the cerebral cortex parallels symptom severity
2
,
3
. We hypothesized that the kinetics of tau spread m...

Alternative Titles

Full title

Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7603860

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7603860

Other Identifiers

ISSN

1078-8956

E-ISSN

1546-170X

DOI

10.1038/s41591-020-0938-9

How to access this item